Structure Therapeutics GPCR
NASDAQ GPCR
$22.46 -0.42 (-1.84%)
As of: Oct 21, 2026 · 10:57 AM EDT

Structure Therapeutics (GPCR) Receivables (2025)

Updated

Structure Therapeutics' Receivables came in at $200 million for Q4 2025.

Analysis

Structure Therapeutics (GPCR) Receivables (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,132.46 Bn 1,101.04 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 614.45 Bn 532.98 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.76 Bn 476.87 Bn 12.70 Bn 13.82 Bn
4 Merck 367.67 Bn 322.05 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.09 Bn 262.08 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.81 Bn 235.50 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.49 Bn 191.89 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.25 Bn 165.45 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.18 Bn 116.83 Bn 10.94 Bn 12.49 Bn
10 Structure Therapeutics 4.90 Bn 3.56 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 200.00 Mn
API Access

Structure Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=GPCR&period=max&api_key=YOUR_API_KEY